|
1
|
Pal SK, Reckamp K, Yu H and Figlin RA: Akt
inhibitors in clinical development for the treatment of cancer.
Expert Opin Investig Drugs. 19:1355–1366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheung M and Testa JR: Diverse mechanisms
of AKT pathway activation in human malignancy. Curr Cancer Drug
Targets. 13:234–244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chandarlapaty S, Sawai A, Scaltriti M,
Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V, Majumder PK,
Baselga J and Rosen N: AKT inhibition relieves feedback suppression
of receptor tyrosine kinase expression and activity. Cancer Cell.
19:58–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hollander MC, Maier CR, Hobbs EA, Ashmore
AR, Linnoila RI and Dennis PA: Akt1 deletion prevents lung
tumorigenesis by mutant K-ras. Oncogene. 30:1812–1821. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Romano G: The role of the dysfunctional
akt-related pathway in cancer: Establishment and maintenance of a
malignant cell phenotype, resistance to therapy, and future
strategies for drug development. Scientifica (Cairo).
2013:3171862013.
|
|
6
|
Virtakoivu R, Pellinen T, Rantala JK,
Perälä M and Ivaska J: Distinct roles of AKT isoforms in regulating
β1-integrin activity, migration, and invasion in prostate cancer.
Mol Biol Cell. 23:3357–3369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gonzalez E and McGraw TE: The Akt kinases:
Isoform specificity in metabolism and cancer. Cell Cycle.
8:2502–2508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garofalo RS, Orena SJ, Rafidi K, Torchia
AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks
JR, et al: Severe diabetes, age-dependent loss of adipose tissue,
and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin
Invest. 112:197–208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katome T, Obata T, Matsushima R, Masuyama
N, Cantley LC, Gotoh Y, Kishi K, Shiota H and Ebina Y: Use of RNA
interference-mediated gene silencing and adenoviral overexpression
to elucidate the roles of AKT/protein kinase B isoforms in insulin
actions. J Biol Chem. 278:28312–28323. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Simons A, Orcutt K, Madsen J, Scarbrough P
and Spitz D: The role of Akt pathway signaling in glucose
metabolism and metabolic oxidative stress. Oxidative Stress in
Cancer Biology and Therapy. Spitz DR, Dornfeld KJ, Krishnan K and
Gius D: Humana Press; New York: pp. 21–46. 2012, View Article : Google Scholar
|
|
12
|
Sahlberg SH, Gustafsson AS, Pendekanti PN,
Glimelius B and Stenerlow B: The influence of AKT isoforms on
radiation sensitivity and DNA repair in colon cancer cell lines.
Tumour Biol. 35:3525–3534. 2014. View Article : Google Scholar :
|
|
13
|
Sahlberg SH, Spiegelberg D, Glimelius B,
Stenerlöw B and Nestor M: Evaluation of cancer stem cell markers
CD133, CD44, CD24: association with AKT isoforms and
radioresistance in colon cancer cells. PLoS One. e946212014.
View Article : Google Scholar
|
|
14
|
Li C and Wong WH: Model-based analysis of
oligonucleotide arrays: Expression index computation and outlier
detection. Proc Natl Acad Sci USA. 98:31–36. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article3. 2004.
|
|
16
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc B. 57:289–300. 1995.
|
|
17
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sumner LW, Amberg A, Barrett D, Beale MH,
Beger R, Daykin CA, Fan TW, Fiehn O, Goodacre R, Griffin JL, et al:
Proposed minimum reporting standards for chemical analysis Chemical
Analysis Working Group (CAWG) Metabolomics Standards Initiative
(MSI). Metabolomics. 3:211–221. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wishart DS, Jewison T, Guo AC, Wilson M,
Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, et al: HMDB
3.0 - The Human Metabolome Database in 2013. Nucleic Acids Res.
41(D1): D801–D807. 2013. View Article : Google Scholar
|
|
20
|
Trygg J and Wold S: Orthogonal projections
to latent structures (O-PLS). J Chemometr. 16:119–128. 2002.
View Article : Google Scholar
|
|
21
|
Makrilia N, Kollias A, Manolopoulos L and
Syrigos K: Cell adhesion molecules: Role and clinical significance
in cancer. Cancer Invest. 27:1023–1037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ericson K, Gan C, Cheong I, Rago C,
Samuels Y, Velculescu VE, Kinzler KW, Huso DL, Vogelstein B and
Papadopoulos N: Genetic inactivation of AKT1, AKT2, and PDPK1 in
human colorectal cancer cells clarifies their roles in tumor growth
regulation. Proc Natl Acad Sci USA. 107:2598–2603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takebe N, Nguyen D and Yang SX: Targeting
notch signaling pathway in cancer: Clinical development advances
and challenges. Pharmacol Ther. 141:140–149. 2014. View Article : Google Scholar :
|
|
24
|
Phillips TM, McBride WH and Pajonk F: The
response of CD24−/low/CD44+ breast
cancer-initiating cells to radiation. J Natl Cancer Inst.
98:1777–1785. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu SK, Bham SA, Fokas E, Beech J, Im J,
Cho S, Harris AL and Muschel RJ: Delta-like ligand 4-notch blockade
and tumor radiation response. J Natl Cancer Inst. 103:1778–1798.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Sousa EM, Vermeulen L, Richel D and
Medema JP: Targeting Wnt signaling in colon cancer stem cells. Clin
Cancer Res. 17:647–653. 2011. View Article : Google Scholar
|
|
27
|
Yang J, Zhang W, Evans PM, Chen X, He X
and Liu C: Adenomatous polyposis coli (APC) differentially
regulates beta-catenin phosphorylation and ubiquitination in colon
cancer cells. J Biol Chem. 281:17751–17757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sur S, Pagliarini R, Bunz F, Rago C, Diaz
LA Jr, Kinzler KW, Vogelstein B and Papadopoulos N: A panel of
isogenic human cancer cells suggests a therapeutic approach for
cancers with inactivated p53. Proc Natl Acad Sci USA.
106:3964–3969. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
DeBerardinis RJ, Mancuso A, Daikhin E,
Nissim I, Yudkoff M, Wehrli S and Thompson CB: Beyond aerobic
glycolysis: Transformed cells can engage in glutamine metabolism
that exceeds the requirement for protein and nucleotide synthesis.
Proc Natl Acad Sci USA. 104:19345–19350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Currie E, Schulze A, Zechner R, Walther TC
and Farese RV Jr: Cellular fatty acid metabolism and cancer. Cell
Metab. 18:153–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oermann EK, Wu J, Guan KL and Xiong Y:
Alterations of metabolic genes and metabolites in cancer. Semin
Cell Dev Biol. 23:370–380. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johansson K, Ahlen K, Rinaldi R, Sahlander
K, Siritantikorn A and Morgenstern R: Microsomal glutathione
transferase 1 in anticancer drug resistance. Carcinogenesis.
28:465–470. 2007. View Article : Google Scholar
|
|
34
|
Cho SG, Lee YH, Park HS, Ryoo K, Kang KW,
Park J, Eom SJ, Kim MJ, Chang TS, Choi SY, et al: Glutathione
S-transferase mu modulates the stress-activated signals by
suppressing apoptosis signal-regulating kinase 1. J Biol Chem.
276:12749–12755. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi SW and Mason JB: Folate and
carcinogenesis: An integrated scheme. J Nutr. 130:129–132.
2000.PubMed/NCBI
|
|
36
|
Harmenberg U, Frodin JE, Ljungdahl-Stahle
E, Mellstedt H, Wahren B and Stigbrand T: Significance of alkaline
phosphatase isozymes in the monitoring of patients with colorectal
carcinoma. Tumour Biol. 10:225–231. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cho YR, Kim SH, Ko HY, Kim MD, Choi SW and
Seo DW: Sepiapterin inhibits cell proliferation and migration of
ovarian cancer cells via down-regulation of p70S6K-dependent
VEGFR-2 expression. Oncol Rep. 26:861–867. 2011.PubMed/NCBI
|
|
38
|
Lamarre SG, Morrow G, Macmillan L, Brosnan
ME and Brosnan JT: Formate: an essential metabolite, a biomarker,
or more? Clin Chem Lab Med. 51:571–578. 2013. View Article : Google Scholar
|
